Vincent Leroy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Vincent Leroy

Showing results (171-180 of 172) with videos related to

Pageof 18

Sort By:

You have reached the last page of results.This site can display upto 172 results.

Journal of Medicinal Chemistry|November 18, 2014

Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.

Gastroenterology|September 20, 2016

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver ComplicationsPierre Nahon, Valérie Bourcier, Richard Layese, et al.

Pageof 18

Search research articles

Showing results (171-180 of 172) with videos related to

Sort By:

Pageof 18

You have reached the last page of results.This site can display upto 172 results.

Journal of Medicinal Chemistry|November 18, 2014

Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.

Gastroenterology|September 20, 2016

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver ComplicationsPierre Nahon, Valérie Bourcier, Richard Layese, et al.

Pageof 18